Amesino

Business Data, Corporate Office and Headquarter Address

About

Amesino is Drug Discovery in United States that focus on developer business. Founded in 2015. They cover business area such as developer, cancer drug, cancer disease, discovery.

Business Type

Drug Discovery

Country

United States

Founded

2015
( 9 years old in 2024 )

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

1500 1st Avenue
North L109
Birmingham, AL 35203
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developercancer drugcancer diseasediscovery

* We use standard office opening hours in near Amesino's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Amesino Frequently Asked Questions

What or who is Amesino?

Amesino is Drug Discovery business from United States that founded in 2015 (9 years old in 2024), Amesino business is focusing on Developer.

Where is Amesino headquarter and corporate office address?

Amesino headquarter office and corporate office address is located in 1500 1st Avenue North L109 Birmingham, AL 35203 United States.

Where is Amesino country origins?

Amesino was founded in United States.

What is Developer business focus on?

In 2024, Amesino is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Amesino, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.